ORGANON & COOO

ORGANON & CO

309.00MXND
−21.11−6.39%
At close at Feb 18, 14:30 GMT
MXN
No trades
See on Supercharts
Next report date
May 1
Report period
Q1 2025
EPS estimate
19.01 MXN
Revenue estimate
‪31.62 B‬ MXN
Market capitalization
‪81.54 B‬MXN
70.08MXN
‪18.01 B‬MXN
‪133.50 B‬MXN
‪256.98 M‬
Beta (1Y)
0.27

About Organon & Co.


CEO
Kevin Ali
Headquarters
Jersey City
Founded
2020
FIGI
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Performance
‪6.5%‬
‪13.5%‬
‪20.5%‬
‪27.5%‬
‪34.5%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪9.00 B‬‬
‪‪18.00 B‬‬
‪‪27.00 B‬‬
‪‪36.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪9.00 B‬‬
‪‪18.00 B‬‬
‪‪27.00 B‬‬
‪‪36.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪9.00 B‬‬
‪‪18.00 B‬‬
‪‪27.00 B‬‬
‪‪36.00 B‬‬
Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪50.00 B‬‬
‪‪100.00 B‬‬
‪‪150.00 B‬‬
‪‪200.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:May 1, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪6.00‬
‪12.00‬
‪18.00‬
‪24.00‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MRK5808585
Organon & Co. 7.875% 15-MAY-2034
Yield to maturity
7.51%
Maturity date
May 15, 2034
MRK5164077
Organon Finance 1 LLC 5.125% 30-APR-2031
Yield to maturity
7.49%
Maturity date
Apr 30, 2031
MRK5808583
Organon & Co. 6.75% 15-MAY-2034
Yield to maturity
6.61%
Maturity date
May 15, 2034
MRK5164075
Organon Finance 1 LLC 4.125% 30-APR-2028
Yield to maturity
6.09%
Maturity date
Apr 30, 2028
XS233225070
ORGANON/ORG.F. 21/28 REGS
Yield to maturity
3.84%
Maturity date
Apr 30, 2028

Explore more bonds 

Frequently Asked Questions


The current price of OGN is 309.00 MXN — it has decreased by −6.39% in the past 24 hours. Watch ORGANON & CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange ORGANON & CO stocks are traded under the ticker OGN.
OGN stock has fallen by −5.15% compared to the previous week, the month change is a −17.77% fall, over the last year ORGANON & CO has showed a 4.16% increase.
We've gathered analysts' opinions on ORGANON & CO future price: according to them, OGN price has a max estimate of 589.18 MXN and a min estimate of 304.75 MXN. Watch OGN chart and read a more detailed ORGANON & CO stock forecast: see what analysts think of ORGANON & CO and suggest that you do with its stocks.
OGN stock is 6.83% volatile and has beta coefficient of 0.27. Track ORGANON & CO stock price on the chart and check out the list of the most volatile stocks — is ORGANON & CO there?
Today ORGANON & CO has the market capitalization of ‪81.54 B‬, it has decreased by −2.34% over the last week.
Yes, you can track ORGANON & CO financials in yearly and quarterly reports right on TradingView.
ORGANON & CO is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
OGN earnings for the last quarter are 18.76 MXN per share, whereas the estimation was 18.08 MXN resulting in a 3.79% surprise. The estimated earnings for the next quarter are 19.01 MXN per share. See more details about ORGANON & CO earnings.
ORGANON & CO revenue for the last quarter amounts to ‪33.19 B‬ MXN, despite the estimated figure of ‪33.20 B‬ MXN. In the next quarter, revenue is expected to reach ‪31.62 B‬ MXN.
OGN net income for the last quarter is ‪2.27 B‬ MXN, while the quarter before that showed ‪7.07 B‬ MXN of net income which accounts for −67.87% change. Track more ORGANON & CO financial stats to get the full picture.
Yes, OGN dividends are paid quarterly. The last dividend per share was 5.72 MXN. As of today, Dividend Yield (TTM)% is 7.23%. Tracking ORGANON & CO dividends might help you take more informed decisions.
ORGANON & CO dividend yield was 7.51% in 2024, and payout ratio reached 33.63%. The year before the numbers were 7.77% and 28.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORGANON & CO EBITDA is ‪36.74 B‬ MXN, and current EBITDA margin is 26.18%. See more stats in ORGANON & CO financial statements.
Like other stocks, OGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORGANON & CO stock right from TradingView charts — choose your broker and connect to your account.